Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Daniel, M. F."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jaouad Azzahhafi, Thomas O. Bergmeijer, Wout W. A. van den Broek, Dean R. P. P. Chan Pin Yin, Senna Rayhi, Joyce Peper, Willem L. Bor, Daniel M. F. Claassens, Ron H. N. van Schaik, Jurriën M. ten Berg
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aims: To determine the clinical efficacy, adverse events and side-effect dyspnea of CYP3A4*22 and CYP3A5 expressor status in ticagrelor treated patients.Methods and results: Ticagrelor treated patients from the POPular Genetics randomized controlled
Externí odkaz:
https://doaj.org/article/7ac9d46665ce483189d6a3185410c1aa
Autor:
Abdullah M. Al-Rubaish, Fahad A. Al-Muhanna, Abdullah M. Alshehri, Mohammed A. Al-Mansori, Rudaynah A. Alali, Rania M. Khalil, Khalid A. Al Faraidy, Cyril Cyrus, Mohammed M. Sulieman, Chittibabu Vatte, Daniel M. F. Claassens, Jurriën M. ten Berg, Folkert W. Asselbergs, Amein K. Al-Ali
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background To mitigate the risk of stent thrombosis, patients treated by percutaneous coronary intervention (PCI) are administered dual anti-platelet therapy comprising aspirin and a platelet P2Y12 receptor inhibitor. Clopidogrel is a prodru
Externí odkaz:
https://doaj.org/article/75f51cb0afee4ee6b316c40a606decce
Autor:
Bakhtawar K. Mahmoodi, Niclas Eriksson, Stephanie Ross, Daniel M. F. Claassens, Folkert W. Asselbergs, Karina Meijer, Agneta Siegbahn, Stefan James, Guillaume Pare, Lars Wallentin, Jurriën M. ten Berg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Whether factor V Leiden is associated with lower bleeding risk in patients with acute coronary syndromes using (dual) antiplatelet therapy has yet to be investigated. Methods and Results We pooled data from 3 randomized clinical trials, co
Externí odkaz:
https://doaj.org/article/fd44ded4e1244c748e43c5b5fe232661
Autor:
Jeehoon Kang, Konstantinos D Rizas, Kyung Woo Park, Jaewook Chung, Wout van den Broek, Daniel M F Claassens, Eun ho Choo, Dániel Aradi, Steffen Massberg, Doyeon Hwang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Kiyuk Chang, Jur M ten Berg, Dirk Sibbing, Bon-Kwon Koo, Hyo-Soo Kim
Publikováno v:
European Heart Journal, 44(15), 1360-1370. Oxford University Press
Aims Dual-antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is the standard treatment for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). De-escalation of the potent P2Y12 inhibtor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708a28c9e991e0a8e434e04c7a8cbe6d
https://doi.org/10.1093/eurheartj/ehac829
https://doi.org/10.1093/eurheartj/ehac829
Autor:
Daniel M. F. Palhares, Milena S. Marcolino, Thales M. M. Santos, José L. P. da Silva, Paulo R. Gomes, Leonardo B. Ribeiro, Peter W. Macfarlane, Antonio L. P. Ribeiro
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-23 (2017)
Abstract Background Knowledge of the normal limits of the electrocardiogram (ECG) is mandatory for establishing which patients have abnormal ECGs. No studies have assessed the reference standards for a Latin American population. Our aim was to establ
Externí odkaz:
https://doaj.org/article/98c022b87373444e94baf43252faff30
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Claassens, Daniel M F, Vos, Gerrit J A, Bergmeijer, Thomas O, Hermanides, Renicus S, van 't Hof, Arnoud W J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul R, Dewilde, Willem J M, Janssen, Paul W A, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Boersma, Cornelis, Deneer, Vera H M, Ten Berg, Jurriën M, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology
Publikováno v:
New England Journal of Medicine, 381(17), 1621-1631. MASSACHUSETTS MEDICAL SOCIETY
New England Journal of Medicine, 381(17), 1621-1631. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 381, 1621. Massachussetts Medical Society
New England Journal of Medicine, 381(17), 1621. Massachussetts Medical Society
New England Journal of Medicine, 381(17), 1621-1631. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 381, 1621. Massachussetts Medical Society
New England Journal of Medicine, 381(17), 1621. Massachussetts Medical Society
BackgroundIt is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2Y(12) inhibitors.MethodsWe conducted a randomized, open-label, assessor-blinded trial in which patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733c98faebcd29c4b96c53bc67fcb7de
https://hdl.handle.net/11370/650391a9-784b-433f-a595-a7bf8062502a
https://hdl.handle.net/11370/650391a9-784b-433f-a595-a7bf8062502a
Autor:
Claassens, Daniel M. F.1 d.claassens@antoniusziekenhuis.nl, Coers, Djura O.2, Bergmeijer, Thomas O.1, Chan Pin Yin, Dean R. P. P.1, Ten Berg, Jurriën M.1
Publikováno v:
Emergency Care Journal. 2019, Vol. 15 Issue 2, p51-56. 6p.